The upcoming total lunar eclipse over Asia and the partial solar eclipse over Antarctica occurring in September will be highlighted during “Wyoming Skies” programs at the University of Wyoming Harry C ...

We're working continuously to improve our search results. If you aren't finding what you expect, please use our feedback form to share the search query and expected ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the combination of tobevibart and ...

We're working continuously to improve our search results. If you aren't finding what you expect, please use our feedback form to share the search query and expected result with us so we can improve.

The Defense Advanced Research Projects Agency, in collaboration with all service branches of the Department of Defense, has launched the Resilient Software Systems Capstone program to address software ...

BRUSSELS, June 12, 2025 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source software foundations, today announced the upcoming 0.5 release of the Safety Open Vehicle ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...